11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy

Lemonitsa H. Mammatas; Maqsood Yaqub; N. Harry Hendrikse; Otto S. Hoekstra; Richard J. Honeywell; Robert C. Schuit; Martijn Meijerink; Lothar A. Schwarte; Godefridus J. Peters; Henk M.W. Verheul; Adriaan A. Lammertsma; C. Willemien Menke-van der Houven van Oordt

doi:10.2967/jnumed.120.251611

Research ArticleOncology

¹¹C-Sorafenib and ¹⁵O-H₂O PET for Early Evaluation of Sorafenib Therapy

Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt

Journal of Nuclear Medicine July 2021, 62 (7) 934-940; DOI: https://doi.org/10.2967/jnumed.120.251611

Lemonitsa H. Mammatas

1Department of Medical Oncology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

2Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maqsood Yaqub

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

N. Harry Hendrikse

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Otto S. Hoekstra

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard J. Honeywell

1Department of Medical Oncology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert C. Schuit

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martijn Meijerink

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lothar A. Schwarte

4Department of Anesthesiology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Godefridus J. Peters

1Department of Medical Oncology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

5Department of Biochemistry, University of Gdansk, Gdansk, Poland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Henk M.W. Verheul

1Department of Medical Oncology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

6Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adriaan A. Lammertsma

3Department of Radiology and Nuclear Medicine, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

C. Willemien Menke-van der Houven van Oordt

1Department of Medical Oncology, VUmc, Amsterdam UMC, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 7

July 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹¹C-Sorafenib and ¹⁵O-H₂O PET for Early Evaluation of Sorafenib Therapy

Journal of Nuclear Medicine Jul 2021, 62 (7) 934-940; DOI: 10.2967/jnumed.120.251611

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹¹C-Sorafenib and ¹⁵O-H₂O PET for Early Evaluation of Sorafenib Therapy

Journal of Nuclear Medicine Jul 2021, 62 (7) 934-940; DOI: 10.2967/jnumed.120.251611

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology

Role of PET/CT in the management of multiple myeloma
FDG-PET/CT and NaF-PET/CT in the diagnosis and assessment of radiation therapy-induced vascular complications in patients with head and neck cancer
18F-FDG PET/CT manifestations of three Cases of Female Desmoplastic Small Round Cell Tumor

Show more Oncology

Clinical

Detection of Early Progression with ¹⁸F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker

Show more Clinical

Keywords

imaging biomarker
PET/CT
11C-sorafenib
15O-H2O
intratumor drug concentration

Main menu

User menu

Search

¹¹C-Sorafenib and ¹⁵O-H₂O PET for Early Evaluation of Sorafenib Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Clinical

Similar Articles

Keywords